<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-042815</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>García Nieto, V</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Nefrologia;25(5): 578-579, sept.-oct. 2005. tab</dc:source>
<dc:identifier>ibc-042815</dc:identifier>
<dc:title xml:lang="es">¿El defecto para acidificar la orina en la prueba realizada con furosemida, es un marcador de resistencia?</dc:title>
<dc:subject>^d7014</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d5801^s22044</dc:subject>
<dc:subject>^d14970^s22044</dc:subject>
<dc:subject>^d2715</dc:subject>
<dc:subject>^d22164</dc:subject>
<dc:subject>^d14970^s22050</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d4294^s22044</dc:subject>
<dc:subject>^d4294</dc:subject>
<dc:type>article</dc:type>
<dc:date>200510</dc:date>
</metadata>
</record>
</ibecs-document>
